Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Environ Int. 2017 Sep 5;108:212–220. doi: 10.1016/j.envint.2017.08.018

Serum Polychlorinated Biphenyls and Leukocyte Telomere Length in a Highly-Exposed Population: The Anniston Community Health Survey

Catherine L Callahan a,1,*, Marian Pavuk b, Linda S Birnbaum c, Xuefeng Ren a, James R Olson a, Matthew R Bonner a
PMCID: PMC5623110  NIHMSID: NIHMS905388  PMID: 28886414

Abstract

Background

Serum polychlorinated biphenyls (PCBs) have previously been associated with longer leukocyte telomere length (LTL) in most, but not all, of the few previous studies. PCBs were produced in Anniston, Alabama from 1929–1971 and participants of the Anniston Community Health Survey (ACHS) were highly exposed.

Objectives

We evaluated serum levels of 35 PCBs and relative telomere length in 559 ACHS participants.

Methods

Relative LTL was measured in DNA extracted from blood clots. We assessed PCBs individually, grouped by chlorination, and summed PCBs. We used linear regression to assess the association between each PCB metric while adjusting for pertinent covariates.

Results

Serum PCBs were associated with longer LTL among white participants and the oldest age group of black participants. Among white participants, compared with those in the first quartile of sum PCBs those in the third quartile of sum PCBs had 8.09% longer relative LTL (95% CI: 1.99; 14.55) and those in the fourth had 7.58% longer relative LTL (95%CI: −0.01; 15.76) (p-quadratic = 0.05). Among African American participants, serum PCBs were associated with longer relative LTL among those over age 64 only. Tests for interaction were not statistically significant.

Conclusions

We observed a non-linear positive association between serum PCBs and LTL among white participants. Serum PCBs were associated with longer LTL in the oldest age group of African Americans. This association may provide insight into the cancers previously associated with exposure to PCBs, melanoma and non-Hodgkin lymphoma, which have been associated with long LTL in previous studies.

Keywords: Polychlorinated biphenyls, Anniston Community Health Survey, telomere length, molecular epidemiology

1 Introduction

Polychlorinated biphenyls (PCBs) are a class of 209 organic synthetic chemicals with one to ten chlorine atoms attached to the biphenyl ring, that were previously used in a variety of commercial applications (Warner et al., 2012). Manufacture of PCBs was banned in the United States in 1977. Because of their persistence in the environment PCBs can be detected in air, seawater, lake and river sediments (Li et al., 2009; Warner et al., 2012). The toxicity a PCB congener exerts is dictated by the number and positioning of chlorines atoms on the two phenyl rings. Non-ortho PCBs are congeners lacking chlorines at the 2, 6, 2′, and 6′ position that bind to the aryl-hydrocarbon receptor (AhR) to exert dioxin-like effects. PCBs containing one chlorine in an ortho position (mono-ortho) bind to the AhR, but with less affinity than non-ortho PCBs (Lauby-Secretan et al., 2016). It is established that AhR binding induces the expression of a number of genes that contribute to carcinogenesis via deregulation of several cell-cycle and signal transduction pathways (Wall et al., 2015). Adverse health effects caused by PCBs independent of AhR binding are active areas of investigation. Alternate mechanisms of PCB-induced toxicity include oxidative stress, genotoxic effects, immune suppression, inflammatory response and endocrine disruption (Lauby-Secretan et al., 2016). The degree to which these mechanisms are exerted is likely congener and pathway specific.

Telomeres are caps on the ends of chromosomes consisting of tandem nucleotide repeats and an associated protein complex called “shelterin”. Telomeres maintain genomic stability by preventing the fusion of chromosomal ends, nucleolytic decay, and atypical recombination (O’Sullivan and Karlseder, 2010). Loss of telomeric DNA during cell division prevents the loss of critical chromatin. Critically short telomeres are recognized as damaged DNA and activate the DNA damage response pathway leading to cellular senescence and apoptosis in normal cells (Sahin and DePinho, 2012). Aging, oxidative stress, and inflammation have been implicated in telomere shortening (Shin et al., 2010). Telomere shortening beyond critical lengths may lead to aberrant recombination, chromosomal fusion, and subsequent neoplasia (Wong et al., 2014). Alternatively, cells with longer telomeres may favor delayed senescence and thus have more potential to acquire genetic abnormalities and subsequent malignant transformation (Lan et al., 2009). Both short and long leukocyte telomere length (LTL) has been associated with increased risk of several types of cancer (Ma et al., 2011; Wentzensen et al., 2011). Short LTL has also been associated with increased risk of cardiovascular disease (Haycock et al., 2014) and type 2 diabetes (Willeit et al., 2014).

In vitro, immortalized human skin keratinocytes, hamster lung fibroblasts, immortalized lymphocytes, or human promyelocytic leukemia cells exposed to PCB 153, PCB 126, PCB 52, PCB 28, or 2-(4′-chlorophenyl)-1, 4-benzoquinone (PCB3pQ), have shortened telomeres (Jacobus et al., 2008; Senthilkumar et al., 2011; Senthilkumar et al., 2012; Xin et al., 2016; Ziegler et al., 2016). Conversely, PCB 138 and PCB 153 upregulate c-myc in vitro (Ghosh et al., 2007; Gribaldo et al., 1998). C-myc is a proto-oncogene that is involved in the reactivation of telomerase (Daniel et al., 2012). Exposure to PCBs is consistently associated with an increased risk of melanoma and to a lesser extent non-Hodgkin lymphoma (NHL) (reviewed by: (IARC et al., 2016)). Longer LTL has been associated with increased risk of melanoma (Caini et al., 2015) or NHL (Hosnijeh et al., 2014; Lan et al., 2009).

To our knowledge, five cross-sectional studies and one longitudinal study have addressed the association between serum PCBs and LTL. The first was a study of 84 healthy Korean participants that reported a positive association between serum levels of PCBs and LTL. However, the four study participants with the highest levels of serum PCBs had shorter telomeres (Shin et al., 2010). Three analyses of National Health and Nutrition Survey (NHANES) participants have also identified a positive association between serum PCBs and longer LTL (Mitro et al., 2015; Patel et al., 2016; Scinicariello and Buser, 2015). In the largest NHANES analysis, comprising 2,175 participants, those in the highest quartile of sum PCBs (>142.80 ng/g) had 11.63% longer telomeres (95% CI:6.18; 17.35) than those in the lowest quartile (Scinicariello and Buser, 2015) . Conversely, in a study of 207 participants occupationally exposed to PCBs and 104 non-occupationally exposed controls, LTL in lymphocytes, but not granulocytes, was shorter among those exposed to PCBs (Ziegler et al., 2016). In the only longitudinal study to date, serum levels of PCB 153 were associated with shorter LTL after ten years of follow-up (Guzzardi et al., 2016).

The Anniston Community Health Survey (ACHS) is a cross-sectional study of residents of Anniston, Alabama, where PCBs were manufactured from 1929–1971. ACHS participants have serum levels of PCBs 1.5 to 3.5 times greater than those of NHANES participants of the same age and race (Pavuk et al., 2014a). To test the hypothesis that PCBs are associated with LTL, we assessed the association between serum levels of 35 PCBs and relative LTL in this highly exposed group.

2 Methods

2.1 The Anniston Community Health Survey (ACHS)

ACHS participants were recruited and completed active study participation between 2005–2007. Two-stage address-based random sampling was used to select 3,320 households from a commercial list of residential sites within Anniston city limits. Addresses in west Anniston, where the former PCB manufacturing facility was located, were intentionally oversampled. Of the addresses identified, 489 were vacant or non-residential and 890 could not be reached after multiple attempts. In total, 1,110 households agreed to participate (39% response rate; 57% participation rate). We used the survey responses to identify participants who reported that a doctor diagnosed them with diabetes, hypertension, or cancer; years of education; smoking status; and other pertinent covariates. Of those who completed the survey, 765 agreed to a clinic visit where they donated fasting blood samples. After centrifuging, 2 mL of serum from each participant was frozen at the ACHS study office in Anniston. The specimens, including blood clot samples used for LTL measurement, were sent on dry ice to CDC’s National Center for Environmental Health (NCEH) laboratory (Atlanta, GA), where they were stored at −70 °C until chemical analysis. All ACHS participants provided informed consent and study protocols were approved by the University of Alabama at Birmingham and University at Buffalo’s Institutional Review Boards.

2.2 Exposure assessment

Serum levels of 35 PCBs were measured by the Center for Disease Control (CDC) National Center for Environmental Health laboratory using high-resolution gas chromatography/isotope dilution high-resolution mass spectrometry, as previously reported (Pavuk et al., 2014a; Sjodin et al., 2004). These congeners were selected because of their relevance to human exposure assessment as previously described. The coefficient of variation for duplicate samples ranged between 2.4 to 11.2 for each congener (Pavuk et al., 2014a). We did not analyze congeners with ≥40% of individuals below the limit of detection, which were: PCB 18, 44, 49, 52, 87, 101, 110, 128, 149, and 151.

2.3 Outcome assessment

Blood clot samples were shipped from the Center for Disease Control (CDC) National Center for Environmental Health laboratory to the University at Buffalo on dry ice in 2015, where they were then stored in at −80 °C until DNA extraction. DNA was extracted from stored blood clot samples using the PureGene protocol and clotspin baskets by Qiagen. Purified DNA was then stored at −80°C prior to telomere assays. Immediately before analysis experimental DNA samples were re-quantified using the NanoDrop spectrophometer and diluted to 4ng/μl using PCR-grade water. Of ACHS participants who donated a blood sample, 585 had blood clot samples available to measure relative LTL. DNA was successfully extracted and relative LTL was measured in 560 of these samples. We excluded one participant who reported their race as Native American.

Relative LTL was measured using monochrome multiplex quantitative polymerase chain reaction as described by Cawthon (Cawthon, 2009). All assays were conducted using 96-well plates and the BioRad CFX-96 Touch real time PCR. Briefly, 6.6μl of DNA were added to each well. The other reagents in the 25μl PCR were 12.5μl Sybr green master mix, 5μl betaine, and 0.225μl of the four primers. The four primers 5′-3′ were telg: ACA CTA AGG TTT GGG TTT GGG TTT GGG TTT GGG TTA GTG T, telc: TGT TAG GTA TCC CTA TCC CTA TCC CTA TCC CTA TCC CTA ACA, hbgu: CGG CGG CGG GCG GCG CGG GCT GGG CGG CTT CAT CCA CGT TCA CCT TG, and hbgd: GCC CGG CCC GCC GCG CCC GTC CCG CCG GAG GAG AAG TCT GCC GTT. The thermocycling profile was as follows: 1 cycle of 15 minutes at 95°C; 2 cycles of 2 seconds at 98°C and 30 seconds at 49°C; 36 cycles of 2 seconds at 98°C, 30 seconds at 59°C, 15 seconds at 74°C with signal acquisition, 30 seconds at 84°C, and 15 seconds at 85°C with signal acquisition. The signal acquisition at 74°C provides the cycle thresholds for telomeres and the signal acquisition at 85°C provides the cycle thresholds for the single copy gene human beta-globin (hbg). Five concentrations of pooled human genomic DNA (Promega) generated via three-fold serial dilution: 150, 50, 16.7, 5.5, and 1.85 ng were included in each plate in duplicate to generate standard curves.

BioRad CFX manager software was used to determine the telomere (T) and single copy gene (S) values for each experimental sample using the standard curve. These values were then used to generate a T/S ratio for each sample which was averaged. Samples with a relative LTL less than 1.00 have an average LTL shorter than that of the reference DNA and samples with a relative LTL greater than 1.00 have an average LTL longer than the reference DNA (Cawthon, 2009).

Experimental samples were analyzed in triplicate and the average was reported. The average measures intra-class correlation coefficient for experimental samples was 0.79. Seven percent of samples were analyzed in blind duplicate; the coefficient of variation for these samples was 7.4%.

2.4 Statistical analyses

We used multiple imputation to address missing information on pertinent covariates and values for PCBs for samples that were below the limit of detection. The percent of participants with values above the limit of detection is presented in Table 1. The PROC MI procedure in SAS was used to generate five data sets with plausible values imputed for those missing. We used the Markov chain Monte Carlo method which generates a chain of values long enough that the elements stabilize to the distribution of the variable of interest (Yuan, 2010). Each of the five imputed datasets was analyzed individually using standard statistical procedures. These results were then combined using PROC MIANALYZE to reflect the uncertainty due to the missing values. The first imputed dataset was used to generate percentile cut-points and when presenting counts of participants in tables.

Table 1.

Classification scheme for polychlorinated biphenyls

Grouping/PCB % >LOD
Mono-ortho
 28 84.1
 66 80.3
 74 99.6
 105 95.2
 118 99.8
 156 98.2
 157 89.8
 167 88.2
 189 75.7
Di-ortho
 99 99.1
 138–158 99.8
 146 97.7
 153 100
 170 99.8
 172 89.3
 180 99.6
 194 96.3
Tri and tetra-ortho
 177 93.2
 178 92.5
 183 94.5
 187 99.1
 195 88.9
 196 98.8
 199 98.4
 206 98.9
 209 95.2

We used multivariable linear regression to calculate beta coefficients for the association between natural log-transformed LTL and natural log-transformed PCBs as a continuous variable and quartiles of PCBs. Resulting β coefficients from the continuous PCB analyses were transformed to estimate the predicted percent change in relative LTL per doubling of exposure to serum PCBs using the formula: percent difference in T/S ratio = [eβ*(ln2)− 1] * 100. For analyses where participants were grouped by quartiles of PCBs, we used the first quartile as the reference category and used the formula: percent difference in T/S ratio=[eβ−1] * 100. We also estimated p-values for linear and quadratic trend using a grouped linear and grouped quadratic term.

All analyses were stratified by race. Analysis of covariance (ANCOVA) was used to assess the difference in mean serum levels of sum PCBs by select characteristics, adjusting for age and total lipids. PCBs have varying molecular structures, which can dictate their biochemical impact on humans (Aminov et al., 2013) and there are several ways to classify serum concentrations of PCBs. We grouped congeners based on the number and positions of the chlorines (Table 1).

Potential confounders were identified via their association with PCBs and/or LTL in the scientific literature. We considered age, total serum lipids, plate, physical activity (moderate and vigorous physical activity yes/no), alcohol consumption, smoking status (never, former, current), BMI, years of education, sex, self-reported diagnosis of any cancer, and diabetes. All models were minimally adjusted for age in years, age in years squared, total lipids, and 96-well plate. Serum lipids are also strongly associated with serum PCBs, and how to handle serum lipids in studies of the health effects of PCBs is a thoroughly researched topic (O’Brien et al., 2016; Schisterman et al., 2005). In addition to adjusting for total lipids, we also performed analyses using lipid-adjusted values of PCBs and analyses with lipid-adjusted values of PCBs and total lipids included as a covariate. We adjusted for 96-well plate in order to control for potential between-plate variability. Sex and BMI were forced into adjusted models. Differences in adiposity can introduce variability in the pharmacokinetics of lipid soluble compounds, including PCBs (Wolff et al., 2007). All other covariates were included if they changed the point estimate between sum PCBs and relative LTL by at least ten percent.

To address potential bias due to differential sample availability we considered inverse probability weighting (IPW) scoring methods described by Littman and colleagues (Littman et al., 2010). Using all of data from all1,110 Anniston residents that completed the baseline survey, we developed unconditional logistic regression models, stratified by race, where the dependent variable was inclusion in these analyses. We considered covariates that may be associated with LTL and/or serum PCBs. These covariates were: age in years, education, sex, BMI, smoking status, moderate physical activity, vigorous physical activity, having health insurance, having a personal health care provider, able to afford to see a doctor, income, cancer diagnosis, diabetes, high cholesterol, heart attack, heart disease, heart failure, hypertension, and marital status. Covariates were included if they had a p-value<0.20. An inverse propensity score was calculated for each participant and survey procedures were used in our primary analyses to weight participants by their propensity to be included in these analyses. We note that the ACHS participants included in the analyses presented herein were similar to the entire sample of 1,110 Anniston residents that completed the survey with regards, to age, education level, smoking status, and BMI.

Potential effect modification by age, BMI, and sex was assessed via a stratified analysis and the statistical significance of the effect measure modification was tested using a product term for the covariate and serum PCBs in the adjusted linear regression models. These covariates were selected because effect measure modification has been observed in previous scenarios. African-Americans tend to have longer telomeres than whites (reviewed by: (Rewak et al., 2014)). Additionally, there have been racial differences in other biomarker analyses and PCBs in ACHS, particularly with regards to serum lipids (Aminov et al., 2014). In previous studies, reported associations between exposure to PCBs and several outcomes have varied by sex (Elobeid et al., 2010; Lee et al., 2012).

Statistical analyses were conducted using SPSS version 21.00 (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp) and SAS Enterprise Guide version 4.3 (SAS Institute, Cary, NC).

3 Results

Select characteristics and their association with LTL are presented in Table 2. LTL was inversely associated with age; a one-year increase in age was associated with a 0.08% decrease in relative LTL among whites (95% CI: −0.17; 0.02) a 0.10% decrease in LTL among African Americans (95% CI: −0.20; 0.01). Additionally, the oldest quartile of age had the shortest telomeres among both whites and African Americans.

Table 2.

Percent differences in relative telomere length by select characteristics and race

White
n = 332
African American
n = 227
p interactionb


N % Difference a 95% CI N % Difference a 95% CI
Age (years) 0.56
 per 1-year increase −0.08 −0.17 0.02 −0.10 −0.20 0.01
 <48 99 Referent 83 Referent
 48–64 106 0.47 −3.50 4.60 78 1.08 −2.76 5.11
 >64 127 −3.92 −7.56 −0.14 66 −3.64 −7.45 0.32
p for trend 0.03 0.08

Sex 0.004
 Male 100 Referent 68 Referent
 Female 232 −2.22 −5.53 1.20 159 5.26 1.65 9.01

Body mass index (kg/m2) 0.29
 <25 90 Referent 51 Referent
 25–29.9 114 −1.67 −5.87 2.72 56 1.76 −2.41 6.11
 ≥30 128 −0.82 −4.79 3.30 120 −1.29 −5.90 3.54
p for trend 0.66 0.28

Years of education 0.65
 <12 109 Referent 66 Referent
 12 131 3.06 −0.75 7.01 98 1.66 −2.39 5.87
 >12 92 3.39 −0.80 7.75 63 4.68 0.12 9.45
p for trend 0.10 0.04

Smoking 0.54
 Never 125 Referent 109 Referent
 Former 99 −0.08 −3.93 3.93 39 −4.42 −8.80 −0.16
 Current 108 −3.86 −7.51 −0.06 79 −1.64 −5.26 2.11

Cancer 0.56
 No 268 Referent 205 Referent
 Yes 64 −1.05 −5.10 3.18 22 1.08 −4.54 7.03

Diabetes 0.10
 No 272 Referent 159 Referent
 Yes 60 −1.25 −5.36 3.03 67 3.77 0.01 7.68

All participants
Race
 White 332 Referent
 African American 227 1.71 −0.67 4.15
a

Percent difference estimates were calculated using multiple linear regression and are adjusted for age in years, age squared, and plate. Age estimates are only adjusted for plate

b

p for interaction was generated via the inclusion of an interaction term that included race and the variable of interest in linear regression models

Results of linear regression models assessing the association between serum PCBs grouped by chlorination are presented in Table 3. Among white participants all PCB groupings were generally associated with longer LTL. Di-ortho PCBs were linearly associated with longer LTL, compared with the first quartile, those in the fourth quartile had 9.72% longer telomeres (95% CI: 2.09; 17.93, p trend = 0.01). Conversely the association between tri- and tetra-ortho PCBs and LTL was quadratic, those in the third highest quartile had 8.77% longer telomeres (95% CI: 2.30; 15.66) and those in the highest quartile had 5.45% longer telomeres (95% CI: −2.22; 13.73, p quad= 0.01) than those in the first. Although tests for statistical interaction were not significant, the observed association between serum PCBs and longer LTL was limited to white participants. To account for the non-linear association between LTL and PCBs we modeled interaction terms using splines and they were similarly statistically non-significant (results not shown). Inverse probability weighting did not substantially alter our results (not shown).

Table 3.

Percent differencesa in leukocyte telomere length by serum polychlorinated biphenyls (PCBs), Anniston Community Health Survey Participants

White African American p for interaction


N % Difference 95% CI N % Difference 95% CI
Mono-ortho PCBs
 Per doubling of exposure 1.46 −0.38 3.33 −0.21 −1.47 1.07 0.43
 <179.0 ppt 103 Referent 37 Referent
 179.0–390.2 ppt 98 5.22 −0.22 10.95 41 0.36 −6.10 7.25
 390.2–866.5 ppt 88 2.25 −3.38 8.20 52 3.70 −3.40 11.31
 >866.5 ppt 43 9.58 2.23 17.46 97 0.09 −6.69 7.36
p for trend 0.06 0.93
p quadratic 0.78 0.24

Di-ortho PCBs
 Per doubling of exposure 1.80 0.05 3.57 −0.56 −1.82 0.72 0.15
 <904.4 ppt 103 Referent 37 Referent
 904.4–1915.0 ppt 107 7.67 2.24 13.38 32 0.63 −6.38 8.15
 1915.0–4456.2 ppt 82 9.03 3.03 15.39 58 −1.06 −7.84 6.21
 >4456.2 ppt 40 9.72 2.09 17.93 100 −3.79 −10.41 3.31
p for trend 0.01 0.10
p quadratic 0.06 0.42

Tri and tetra-ortho PCBs
 Per doubling of exposure 0.89 −0.85 2.65 −0.24 −1.47 1.01 0.37
 <284.9 ppt 101 Referent 39 Referent
 284.9–713.4 ppt 102 6.62 0.88 12.69 37 1.54 −5.51 9.12
 713.4–1848.6 ppt 81 8.77 2.30 15.66 59 −1.67 −8.63 5.82
 >1848.6 ppt 48 5.45 −2.22 13.73 92 −0.35 −7.45 7.30
p for trend 0.14 0.71
p quadratic 0.01 0.82

ΣPCBs
 Per doubling of exposure 1.46 −0.26 3.21 −0.45 −1.72 0.83 0.24
 <1403.61 ppt 107 Referent 37 Referent
 1403.61 – 3141.40 ppt 98 7.11 1.60 12.92 36 −1.24 −7.95 5.97
 3141.40 – 7345.35 ppt 84 8.09 1.99 14.55 57 0.49 −6.49 8.01
 >7345.35 ppt 43 7.58 −0.01 15.76 97 −2.70 −9.37 4.46
p for trend 0.06 0.37
p quadratic 0.05 0.46
a

Adjusted for age in years, age in years squared, total lipids, plate, smoking status, diabetes, education, alcohol use in the past 30 days, sex, and body mass index.

The association between relative LTL and individual congeners that were statistically significant are presented in Table 4. PCBs 105, 118, 167, 99, 153, 183, 187,196, and 199 were associated with significantly longer relative LTL among whites. PCB 118 was associated with longer relative LTL among African American participants; we did not observe any other significant associations among African American participants.

Table 4.

Percent differencea in relative telomere length by serum polychlorinated biphenyls (PCBs), ACHS participants

White African American


%Difference 95% CI %Difference 95% CI
PCB 99
 Per doubling of exposure 1.65 0.36 2.94 −0.05 −1.17 1.08
 <29.15 ppt Referent Referent
 29.15–71.60 ppt 2.31 −2.13 6.97 −2.42 −8.74 4.32
 71.60–189.60 ppt 4.67 −0.40 9.99 2.22 −4.68 9.63
 >189.60 ppt 8.84 1.77 16.41 −0.49 −7.20 6.71
p for trend 0.01 0.90
p for quadratic 0.69 0.64

PCB 105
 Per doubling of exposure 1.77 0.40 3.15 0.18 −0.57 0.93
 <7.75 ppt Referent Referent
 7.75–19.10 ppt 2.01 −2.43 6.66 1.30 −4.14 7.05
 19.10–58.20 ppt 3.46 −1.84 9.03 7.15 1.55 13.05
 >58.20 ppt 10.45 3.50 17.87 1.01 −4.12 6.41
p for trend 0.01 0.52
p for quadratic 0.25 0.03

PCB 118
 Per doubling of exposure 1.87 0.55 3.21 0.02 −1.07 1.12
 <49.60 ppt Referent Referent
 49.60–121.60 ppt 3.05 −1.60 7.93 −0.62 −6.71 5.87
 121.60–361.80 ppt 4.70 −0.69 10.38 6.05 −0.65 13.21
 >361.80 ppt 9.88 2.76 17.49 −0.24 −6.89 6.88
p for trend 0.01 0.88
p for quadratic 0.68 0.05

PCB 153
 Per doubling of exposure 1.75 0.26 3.26 −0.74 −1.94 0.47
 <278.75 ppt Referent Referent
 278.75–564.95 ppt 5.40 0.53 10.51 0.67 −6.06 7.89
 564.95–1398.50 ppt 7.08 1.64 12.82 2.39 −4.42 9.70
 >1398.50 ppt 7.62 0.57 15.15 −1.64 −8.26 5.46
p for trend 0.02 0.40
p for quadratic 0.19 0.15

PCB 167
 Per doubling of exposure 1.33 −0.20 2.89 −0.02 −1.20 1.17
 <10.88 ppt Referent Referent
 10.88–22.55 ppt 2.08 −3.00 7.43 1.87 −5.52 9.83
 22.55–57.20 ppt 3.82 −1.65 9.58 1.73 −5.27 9.24
 >57.20 ppt 8.58 1.54 16.10 −0.50 −7.45 6.98
p for trend 0.02 0.63
p for quadratic 0.57 0.33

PCB 183
 Per doubling of exposure 1.60 0.05 3.17 −0.13 −1.34 1.09
 <18.65 ppt Referent Referent
 18.65–39.25 ppt 2.59 −2.12 7.53 −0.53 −7.08 6.49
 39.25–93.40 ppt 5.79 0.42 11.45 3.08 −3.74 10.37
 >93.40 ppt 6.24 −0.80 13.79 0.43 −6.36 7.72
p for trend 0.03 0.83
p for quadratic 0.63 0.40

PCB 187
 Per doubling of exposure 1.22 −0.19 2.64 −0.26 −1.42 0.92
 <68.65 ppt Referent Referent
 68.65–159.50 ppt 5.56 0.42 10.95 2.52 −4.62 10.20
 159.50–394.75 ppt 7.67 1.96 13.70 4.38 −3.07 12.40
 >394.75 ppt 6.01 −0.98 13.49 0.73 −6.65 8.70
p for trend 0.04 0.73
p for quadratic 0.07 0.09

PCB 196
 Per doubling of exposure 1.21 −0.43 2.87 −0.24 −1.57 1.10
 <47.00 ppt Referent Referent
 47.00–110.85 ppt 6.30 0.53 12.40 0.45 −6.38 7.78
 110.85–249.35 ppt 8.59 2.02 15.59 −1.35 −8.59 6.46
 >249.35 ppt 9.23 1.32 17.76 −0.96 −8.11 6.73
p for trend 0.02 0.67
p for quadratic 0.16 0.93

PCB 199
 Per doubling of exposure 0.51 −0.96 1.99 −0.60 −1.82 0.65
 <51.75 ppt Referent Referent
 51.75–132.10 ppt 4.98 −0.78 11.07 −3.28 −9.85 3.77
 132.10–318.30 ppt 7.65 0.92 14.83 −4.34 −11.13 2.96
 >318.30 ppt 2.45 −4.78 10.23 −3.63 −10.50 3.76
p for trend 0.55 0.49
p for quadratic 0.01 0.33
a

Adjusted for age in years, age in years squared, total lipids, plate, smoking status, diabetes, education, sex, alcohol use in the past 30 days, and body mass index.

The primary strategy we used for lipid adjustment was to model wet weight values of PCBs with total lipids included as a covariate. We assessed two alternative strategies to adjust for serum lipids; these were lipid adjusted values of PCBs or lipid adjusted values while including total lipids as a covariate. Neither alternate lipid adjustment method substantially altered our results (not shown).

Analyses stratified by age and race are presented in Table 5. We did not observe any evidence of effect modification by age among white participants. When we restricted analyses to African Americans over age 64, we observed a non-significant positive association between each grouping of PCBs and relative LTL. For instance, a doubling of exposure to sum PCBs was associated with 2.43% longer relative LTL (95% CI: −0.17; 5.09). Results were similar when we excluded prevalent cases of cancer. We did not observe evidence of effect measure modification by BMI or sex (results not shown).

Table 5.

Percent differences in relative telomere length per doubling of exposure to polychlorinated biphenyls (PCBs), by age and race, ACHS participants

% Differencea 95% CI % Differencea 95% CI % Differencea 95% CI p for interaction*
Race Age in years
White <48 years
n = 99
48–64 years
n = 106
>64 years
n = 127
 Mono-ortho 1.14 −2.33 4.75 0.11 −3.66 4.04 2.54 −0.13 5.27 0.84

 Di-ortho 2.03 −1.92 6.14 1.40 −1.96 4.88 1.44 −1.24 4.19 0.75

 Tri and Tetra-ortho 1.64 −2.78 6.26 1.10 −1.95 4.25 0.22 −2.20 2.69 0.94

 ΣPCBs 1.38 −2.10 4.98 1.29 −2.06 4.75 1.57 −1.22 4.45 0.65

African American <48 years
n = 83
48–64 years
n = 78
>64 years
n = 66

 Mono-Ortho −0.06 −2.53 2.48 −1.27 −3.42 0.92 2.33 −0.30 5.03

 Di-Ortho −0.89 −3.33 1.62 −1.49 −3.72 0.79 2.21 −0.36 4.84

 Tri and Tetra-Ortho −0.56 −3.17 2.12 −1.10 −3.17 1.01 2.56 0.11 5.07

 ΣPCBs −0.74 −3.23 1.82 −1.42 −3.64 0.85 2.43 −0.17 5.09
a

Adjusted for age in years, age in years squared, total lipids, plate, diabetes, education, alcohol use in the past 30 days, sex, and body mass index. Percent difference reflects predicted difference in doubling of exposure.

*

p for interaction represents tests for significance of three-way interaction term including age in years, race, and PCBs.

4 Discussion

In a large cross-sectional study of residents near a former PCB manufacturing plant, we observed a positive association between serum PCBs and LTL among white participants, but not African Americans. Among African Americans we only observed a positive association between serum PCBs and LTL among the oldest participants only. However, tests for statistical interaction were not significant.

Our results are consistent with four of the six previous analyses of serum PCBs and LTL. A positive association between LTL and serum concentrations of several PCBs was reported in a study of 84 healthy Korean individuals (Shin et al., 2010). Serum PCBs have been associated with longer LTL in three separate analyses of NHANES participants (Mitro et al., 2015; Patel et al., 2016; Scinicariello and Buser, 2015). In the largest analysis of NHANES participants, when compared with those in the first quartile of sum PCBS, those in the highest quartile had 11.63% longer LTL (95% CI: 6.18; 17.35) (Scinicariello and Buser, 2015). We note that ACHS participants have serum levels of PCBs 1.5–3.5 times higher than NHANES participants of the same race and age category (Pavuk et al., 2014a). Conversely, serum PCBs were associated with shorter LTL in lymphocytes in a study of 207 German individuals occupationally exposed to PCBs via employment for a transformer recycling company. When compared with 104 healthy non-exposed controls, those occupationally exposed had a LTL of lymphocytes 0.77 kb shorter than expected (95 % CI −0.93; −0.61) (Ziegler et al., 2016). In the only longitudinal study to date, serum levels of PCB 153 at baseline were associated with shorter LTL ten years later (r= −0.071, p-value 0.02) (Guzzardi et al., 2016).

In our study, serum PCBs were associated with longer LTL among all white participants but only the oldest category of African Americans. Tests for statistical interaction were not significant, thus it should be noted that these findings could be attributed to chance. Additionally, the age-stratified analyses should be considered exploratory. Mitro and colleagues reported that serum levels of two non-ortho PCBs, PCB 126 and PCB 169, were associated with longer LTL among both white and non-Hispanic black NHANES 2001–2002 participants, but not Mexican Americans (Mitro et al., 2015). Racial differences in LTL are important to consider in epidemiologic studies. African Americans tend to have longer telomeres (Hunt et al., 2008; Lynch et al., 2016; Rewak et al., 2014) and a faster rate of telomere attrition than whites (Diez Roux et al., 2009), although this is not observed in all studies (Diez Roux et al., 2009; Okuda et al., 2002), including ours. Additionally, a statistical interaction by race has been reported in studies of cardiovascular disease and LTL (Carty et al., 2015). The biologic mechanism for an association between serum PCBs and longer LTL among white but not African American participants is unclear and warrants further investigation.

Our results are inconsistent with the findings of prior in vitro studies that observed telomere shortening because of exposure to PCB 153, PCB 126, PCB 52, PCB 28, or 2-(4′-chlorophenyl)-1, 4-benzoquinone (PCB3pQ) (Jacobus et al., 2008; Senthilkumar et al., 2011; Senthilkumar et al., 2012; Xin et al., 2016; Ziegler et al., 2016). Alternative mechanisms by which PCBs may induce telomere lengthening have been proposed (Scinicariello and Buser, 2015). Namely, through activation of the proto-oncogene c-myc (Ghosh et al., 2007; Gribaldo et al., 1998), which in turn induces telomerase expression (Gabay et al., 2014).

Cells with longer telomeres have a greater proliferative potential and may be more likely to acquire somatic mutations (Hanahan and Weinberg, 2011). Long LTL has been associated with increased risk of non-Hodgkin’s lymphoma (NHL) (Lan et al., 2009) and melanoma (Anic et al., 2013; Burke et al., 2013; Han et al., 2009; Nan et al., 2011). Exposure to PCBs has also been associated with increased risk of NHL and melanoma, which offers a compelling biologic rationale for the observed association between serum PCBs and long LTL (Joyce and Hou, 2015). In a cohort study of 24,865 capacitor-manufacturing workers exposed to PCBs mortality from melanoma was elevated among those employed for three months or more [standardized mortality ratio= 1.41, 95% CI 1.01;1.91] (Ruder et al., 2014). Case-control studies, including nested case-control studies that measured PCBs prior to diagnosis of NHL, have generally reported that exposure to PCBs are associated with an increased risk of NHL (reviewed by: (Kramer et al., 2012)). An analysis of three nested case-control studies from three prospective cohort studies reported that serum PCBs were consistently associated with elevated risk of NHL. For instance, when compared with the first quartile of PCB 153 those in the fourth were at a 3.6-fold higher odds of being a NHL case (95% CI: 1.3; 9.9)(Engel et al., 2007).

Our study has several limitations that should be considered when interpreting our results. Non-ortho dioxin-like PCBs were not assessed in ACHS, which may be important with regards to PCBs and LTL (Mitro et al., 2015). The cross-sectional design of ACHS implies that temporality between exposure to PCBs and LTL is unclear. Exposure to PCBs may be associated with chronic diseases that could lead to telomere shortening. Furthermore, the rate of telomere shortening may be more etiologically relevant than absolute LTL (Hou et al., 2015), thus additional longitudinal studies are needed.

We used several approaches to identify and reduce potential confounding. LTL generally shortens with age (Muezzinler et al., 2013) and older age is a strong predictor of serum PCBs generally and among ACHS participants (Pavuk et al., 2014a). Since we observed a positive association between serum PCBS and LTL among whites and thoroughly adjusted for age, it seems unlikely that confounding by age is an alternate explanation for our results. Other potentially important confounders that were not addressed in this analysis because the information was not available are pack-years of smoking, secondhand smoke exposure, and diet. We only had a relatively crude measure of tobacco smoke exposure, which was a categorical variable that included never, former, and current smoking. However, adjustment for smoking status strengthened the measures of association we reported among white participants. Thus, if we had a more precise measure of smoking history we would expect to see an even stronger positive association between serum PCBs and white participants. Closer adherence to the Mediterranean Diet, which emphasizes fish consumption, has been associated with longer telomeres (Crous-Bou et al., 2014; García-Calzón et al.; Zhou et al., 2016), while local fish consumption is a predictor of serum PCBs in ACHS (Pavuk et al., 2014b). We did not have information on non-local dietary components and the prevalence of local fish consumption in ACHS was high. Adjustment for other lifestyle factors often associated with diet, such as diabetes, physical activity, and BMI did not substantially alter our results, which provides limited reassurance that unmeasured confounding is not an alternative explanation for our results. Perceived stress, which has been associated with shorter LTL (Mathur et al., 2016), should also be considered as potential confounder in our study because ACHS participants were aware of the environmental contamination and resulting litigation. It seems unlikely that confounding by perceived stress would lead to our observed results, since we found that serum PCBs were associated with longer LTL and all our study participants were residents of Anniston.

Selection bias is another potential limitation, as with most recent epidemiologic studies we had a relatively low response rate of potential participants. Individuals who enroll in epidemiologic studies tend to be more health conscious than those who do not and in our study ACHS participants may be more aware of PCB contamination and litigation than those who opted not to participate. Additionally, this analysis relied on stored blood samples, which were not available for all participants, either because they did not have any remaining blood samples or chose not to donate a blood sample. If inclusion in this analysis was associated with both LTL and serum concentrations of PCBs, then there may be a distortion in our findings. We used IPW to partially address the potential selection bias and found that the measures of association were either unchanged or strengthened (results not shown). This provides some reassurance that selection bias is not a likely alternative explanation for our results. However, the IPW method was based on ACHS participants that at least completed the survey, which does not include Anniston residents who declined to participate.

Our study has several important strengths. Serum PCBs were well-characterized; the reported coefficients of variation were between 2.4 and 11.2% for each congener (Pavuk et al., 2014a). All samples in our study were extracted using the same method; previous studies have indicated that telomere length can vary by DNA extraction method (Hofmann et al., 2014). We also had good quality control for measures for the LTL assay. The intra-class correlation coefficient for LTL was 0.79 and the coefficient of variation for these samples analyzed in blind duplicate was 7.4%. Furthermore, Anniston represents a unique setting to conduct these analyses because the residents of Anniston were exposed to extremely high levels of PCBs and there is wide variability in exposure.

In conclusion, in a highly exposed population we observed a positive association between serum PCBs and LTL among all white participants and the oldest group of African American participants. Our findings build on the expanding body of research indicating that PCBs are associated with longer LTL. However, future prospective studies that address potential confounding factors, particularly diet and weight change, measure LTL across different tissues, and assess incidence of disease are needed to further elucidate our findings.

Highlights.

  • Polychlorinated biphenyls (PCBs) have been associated with certain cancers.

  • Alterations in leukocyte telomere length (LTL) may play a role.

  • We assessed serum PCBs and LTL in a highly exposed population.

  • Serum PCBs were associated with longer LTL among white participants.

  • Serum PCBs were not associated with LTL among African Americans.

Acknowledgments

This work was supported by funding by the National Cancer Institute (NCI) grant R25CA113951 and the intramural research program of NCI/NIH.

Footnotes

Conflict of interest:

J.R. Olson has served as an expert witness for the plaintiffs in legal actions relating to exposure of residents of Anniston, Alabama, to PCBs.

The other authors declare they have no actual or potential competing financial interests.

Disclaimer:

This article was prepared while Catherine Callahan was employed at the University at Buffalo. The opinions expressed in this article are the author’s own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Aminov Z, et al. Racial differences in levels of serum lipids and effects of exposure to persistent organic pollutants on lipid levels in residents of Anniston, Alabama. Environ Int. 2014;73:216–23. doi: 10.1016/j.envint.2014.07.022. [DOI] [PubMed] [Google Scholar]
  2. Aminov Z, et al. Analysis of the effects of exposure to polychlorinated biphenyls and chlorinated pesticides on serum lipid levels in residents of Anniston, Alabama. Environ Health. 2013;12:12–108. doi: 10.1186/1476-069X-12-108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anic GM, et al. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 2013;37:434–9. doi: 10.1016/j.canep.2013.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burke LS, et al. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One. 2013;8:e71121. doi: 10.1371/journal.pone.0071121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Caini S, et al. Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis. J Dermatol Sci. 2015;80:168–74. doi: 10.1016/j.jdermsci.2015.08.003. [DOI] [PubMed] [Google Scholar]
  6. Carty CL, et al. Leukocyte Telomere Length and Risks of Incident Coronary Heart Disease and Mortality in a Racially Diverse Population of Postmenopausal Women. Arterioscler Thromb Vasc Biol. 2015;35:2225–31. doi: 10.1161/ATVBAHA.115.305838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Research. 2009;37:e21. doi: 10.1093/nar/gkn1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crous-Bou M, et al. Mediterranean diet and telomere length in Nurses’ Health Study: population based cohort study. BMJ. 2014:349. doi: 10.1136/bmj.g6674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daniel M, et al. Regulation of the human catalytic subunit of telomerase (hTERT) Gene. 2012;498:135–46. doi: 10.1016/j.gene.2012.01.095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diez Roux AV, et al. Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis. Aging Cell. 2009;8:251–7. doi: 10.1111/j.1474-9726.2009.00470.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elobeid MA, et al. Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999–2002 data. Int J Environ Res Public Health. 2010;7:2988–3005. doi: 10.3390/ijerph7072988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Engel LS, et al. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Res. 2007;67:5545–52. doi: 10.1158/0008-5472.CAN-06-3906. [DOI] [PubMed] [Google Scholar]
  13. Gabay M, et al. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. 2014:4. doi: 10.1101/cshperspect.a014241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. García-Calzón S, et al. Mediterranean diet and telomere length in high cardiovascular risk subjects from the PREDIMED-NAVARRA study. Clinical Nutrition. doi: 10.1016/j.clnu.2016.03.013. [DOI] [PubMed] [Google Scholar]
  15. Ghosh S, et al. Altered protein expressions in chronic PCB-153-induced human liver (HepG2) cells. Int J Toxicol. 2007;26:203–12. doi: 10.1080/10915810701352648. [DOI] [PubMed] [Google Scholar]
  16. Gribaldo L, et al. Modulation of proto-oncogene expression by polychlorinated biphenyls in 3T3-L1 cell line. J Toxicol Environ Health A. 1998;55:121–31. doi: 10.1080/009841098158557. [DOI] [PubMed] [Google Scholar]
  17. Guzzardi MA, et al. Exposure to Persistent Organic Pollutants Predicts Telomere Length in Older Age: Results from the Helsinki Birth Cohort Study. Aging and Disease. 2016;7:540–552. doi: 10.14336/AD.2016.0209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Han J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129:415–21. doi: 10.1038/jid.2008.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. doi: 10.1016/j.cell.2011.02.013. [DOI] [PubMed] [Google Scholar]
  20. Haycock PC, et al. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. Bmj. 2014:8. doi: 10.1136/bmj.g4227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hofmann JN, et al. Telomere length varies by DNA extraction method: implications for epidemiologic research-letter. Cancer Epidemiol Biomarkers Prev. 2014;23:1129–30. doi: 10.1158/1055-9965.EPI-14-0145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hosnijeh FS, et al. Prediagnostic telomere length and risk of B-cell lymphoma—Results from the EPIC cohort study. International Journal of Cancer. 2014;135:2910–2917. doi: 10.1002/ijc.28934. [DOI] [PubMed] [Google Scholar]
  23. Hou L, et al. Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort. EBioMedicine. 2015;2:591–596. doi: 10.1016/j.ebiom.2015.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hunt SC, et al. Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell. 2008;7:451–8. doi: 10.1111/j.1474-9726.2008.00397.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. IARC, et al. Polychlorinated Biphenyls and Polybrominated Biphenyls. World Health Organization; 2016. [Google Scholar]
  26. Jacobus JA, et al. 2-(4′-chlorophenyl)-1,4-benzoquinone increases the frequency of micronuclei and shortens telomeres. Environ Toxicol Pharmacol. 2008;25:267–272. doi: 10.1016/j.etap.2007.10.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Joyce BT, Hou L. Organic Pollutants and Telomere Length: A New Facet of Carcinogenesis. EBioMedicine. 2015;2:1854–1855. doi: 10.1016/j.ebiom.2015.11.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kramer S, et al. Current status of the epidemiologic evidence linking polychlorinated biphenyls and non-hodgkin lymphoma, and the role of immune dysregulation. Environ Health Perspect. 2012;120:1067–75. doi: 10.1289/ehp.1104652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lan Q, et al. A Prospective Study of Telomere Length Measured by Monochrome Multiplex Quantitative PCR and Risk of Non-Hodgkin Lymphoma. Clinical Cancer Research. 2009;15:7429–7433. doi: 10.1158/1078-0432.CCR-09-0845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lauby-Secretan B, et al. Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds. Environ Sci Pollut Res Int. 2016;23:2220–9. doi: 10.1007/s11356-015-4829-4. [DOI] [PubMed] [Google Scholar]
  31. Lee DH, et al. Associations of persistent organic pollutants with abdominal obesity in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Environ Int. 2012;40:170–8. doi: 10.1016/j.envint.2011.07.010. [DOI] [PubMed] [Google Scholar]
  32. Li A, et al. PCBs in sediments of the Great Lakes--distribution and trends, homolog and chlorine patterns, and in situ degradation. Environ Pollut. 2009;157:141–7. doi: 10.1016/j.envpol.2008.07.014. [DOI] [PubMed] [Google Scholar]
  33. Littman AJ, et al. Assessing nonresponse bias at follow-up in a large prospective cohort of relatively young and mobile military service members. BMC Med Res Methodol. 2010;10:99. doi: 10.1186/1471-2288-10-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lynch SM, et al. Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting. PLoS One. 2016;11:e0146723. doi: 10.1371/journal.pone.0146723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ma H, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 2011;6:10. doi: 10.1371/journal.pone.0020466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mathur MB, et al. Perceived stress and telomere length: A systematic review, meta-analysis, and methodologic considerations for advancing the field. Brain, Behavior, and Immunity. 2016;54:158–169. doi: 10.1016/j.bbi.2016.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mitro SD, et al. Cross-Sectional Associations between Exposure to Persistent Organic Pollutants and Leukocyte Telomere Length among U.S. Adults in NHANES, 2001–2002. Environ Health Perspect. 2015 doi: 10.1289/ehp.1510187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Muezzinler A, et al. A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev. 2013;12:509–19. doi: 10.1016/j.arr.2013.01.003. [DOI] [PubMed] [Google Scholar]
  39. Nan H, et al. Shorter Telomeres Associate with a Reduced Risk of Melanoma Development. Cancer Research. 2011;71:6758–6763. doi: 10.1158/0008-5472.CAN-11-1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. O’Brien KM, et al. Environmental Chemicals in Urine and Blood: Improving Methods for Creatinine and Lipid Adjustment. Environ Health Perspect. 2016;124:220–7. doi: 10.1289/ehp.1509693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. O’Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nature reviews Molecular cell biology. 2010;11:171–181. doi: 10.1038/nrm2848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Okuda K, et al. Telomere Length in the Newborn. Pediatr Res. 2002;52:377–381. doi: 10.1203/00006450-200209000-00012. [DOI] [PubMed] [Google Scholar]
  43. Patel CJ, et al. Systematic correlation of environmental exposure and physiological and self-reported behaviour factors with leukocyte telomere length. International Journal of Epidemiology. 2016 doi: 10.1093/ije/dyw043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pavuk M, et al. Serum concentrations of polychlorinated biphenyls (PCBs) in participants of the Anniston Community Health Survey. Sci Total Environ. 2014a;474:286–97. doi: 10.1016/j.scitotenv.2013.12.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pavuk M, et al. Predictors of serum polychlorinated biphenyl concentrations in Anniston residents. Sci Total Environ. 2014b;496:624–34. doi: 10.1016/j.scitotenv.2014.06.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rewak M, et al. Race-related health disparities and biological aging: does rate of telomere shortening differ across blacks and whites? Biol Psychol. 2014;99:92–9. doi: 10.1016/j.biopsycho.2014.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ruder AM, et al. Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update. Int J Hyg Environ Health. 2014;217:176–87. doi: 10.1016/j.ijheh.2013.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sahin E, DePinho RA. Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol. 2012;13:397–404. doi: 10.1038/nrm3352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Schisterman EF, et al. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect. 2005;113:853–7. doi: 10.1289/ehp.7640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Scinicariello F, Buser MC. Polychlorinated Biphenyls and Leukocyte Telomere Length: An Analysis of NHANES 1999–2002. EBioMedicine. 2015;2:1974–9. doi: 10.1016/j.ebiom.2015.11.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Senthilkumar PK, et al. Airborne polychlorinated biphenyls (PCBs) reduce telomerase activity and shorten telomere length in immortal human skin keratinocytes (HaCat) Toxicol Lett. 2011;204:64–70. doi: 10.1016/j.toxlet.2011.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Senthilkumar PK, et al. PCB153 reduces telomerase activity and telomere length in immortalized human skin keratinocytes (HaCaT) but not in human foreskin keratinocytes (NFK) Toxicol Appl Pharmacol. 2012;259:115–23. doi: 10.1016/j.taap.2011.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Shin JY, et al. Low-dose persistent organic pollutants increased telomere length in peripheral leukocytes of healthy Koreans. Mutagenesis. 2010;25:511–6. doi: 10.1093/mutage/geq035. [DOI] [PubMed] [Google Scholar]
  54. Sjodin A, et al. Semiautomated high-throughput extraction and cleanup method for the measurement of polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum. Anal Chem. 2004;76:1921–7. doi: 10.1021/ac030381+. [DOI] [PubMed] [Google Scholar]
  55. Wall RJ, et al. Characterisation of chlorinated, brominated and mixed halogenated dioxins, furans and biphenyls as potent and as partial agonists of the Aryl hydrocarbon receptor. Environment International. 2015;76:49–56. doi: 10.1016/j.envint.2014.12.002. [DOI] [PubMed] [Google Scholar]
  56. Warner J, et al. Common classification schemes for PCB congeners and the gene expression of CYP17, CYP19, ESR1 and ESR2. Sci Total Environ. 2012;414:81–9. doi: 10.1016/j.scitotenv.2011.10.044. [DOI] [PubMed] [Google Scholar]
  57. Wentzensen IM, et al. The Association of Telomere Length and Cancer: a Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 2011;20:1238–1250. doi: 10.1158/1055-9965.EPI-11-0005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Willeit P, et al. Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis. PLoS One. 2014;9:e112483. doi: 10.1371/journal.pone.0112483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wolff MS, et al. Pharmacokinetic variability and modern epidemiology--the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev. 2007;16:1925–30. doi: 10.1158/1055-9965.EPI-07-0394. [DOI] [PubMed] [Google Scholar]
  60. Wong JY, et al. The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One. 2014:9. doi: 10.1371/journal.pone.0087348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Xin X, et al. Effects of PCB126 and PCB153 on telomerase activity and telomere length in undifferentiated and differentiated HL-60 cells. Environ Sci Pollut Res Int. 2016;23:2173–85. doi: 10.1007/s11356-015-5187-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yuan YC. Multiple imputation for missing data: Concepts and new development (Version 9.0) SAS Institute Inc; Rockville, MD: 2010. p. 49. [Google Scholar]
  63. Zhou M, et al. Influence of diet on leukocyte telomere length, markers of inflammation and oxidative stress in individuals with varied glucose tolerance: a Chinese population study. Nutr J. 2016;15:39. doi: 10.1186/s12937-016-0157-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Ziegler S, et al. Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure. Arch Toxicol. 2016;5:5. doi: 10.1007/s00204-016-1725-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES